CD8+ T specifically recognizes MHC-I on the surface of tumor cells through the MHC-I pathway and is initially activated in cytotoxic T cells (TCL) with a certain activity [81], which is an endogenous recognition pathway that can occur in all nucleated cells. Here, CD8A is linked to neoplasm.